BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,480,025 | -9.0% | 560,500 | +20.8% | 0.69% | -14.2% |
Q2 2023 | $14,809,134 | +4.3% | 463,800 | 0.0% | 0.80% | +42.5% |
Q1 2023 | $14,201,556 | -21.7% | 463,800 | 0.0% | 0.56% | -30.0% |
Q4 2022 | $18,139,218 | +4.7% | 463,800 | +27.5% | 0.80% | -25.0% |
Q3 2022 | $17,331,000 | +23.1% | 363,800 | 0.0% | 1.07% | +32.9% |
Q2 2022 | $14,083,000 | +950.2% | 363,800 | +1454.7% | 0.80% | +1219.7% |
Q1 2022 | $1,341,000 | – | 23,400 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |